Does Dr. FARRANAZ ALVAREZ NUNEZ have financial conflicts of interest?

Dr. FARRANAZ ALVAREZ NUNEZ (MD) has received a total of $427 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $427 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. FARRANAZ ALVAREZ NUNEZ?

According to CMS Open Payments data, Dr. FARRANAZ ALVAREZ NUNEZ received funding from GENZYME CORPORATION ($117), SOBI ($116), and TERUMO BCT ($115).

Does Dr. FARRANAZ ALVAREZ NUNEZ receive research grants or speaking fees?

Dr. FARRANAZ ALVAREZ NUNEZ has received $427 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. FARRANAZ ALVAREZ NUNEZ

MDReal-Time Hydrated

Specialty: Pediatrics, Pediatric Hematology-Oncology

Practice Location: ORLANDO, FL 32806

NPI Number: 1285038687

LIFETIME INDUSTRY VALUE

$427

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALVAREZ NUNEZ is a verified Pediatrics, Pediatric Hematology-Oncology practitioner based in ORLANDO, FL.

Between 2021 and 2025, Dr. ALVAREZ NUNEZ had an overall industry promotional and research financial footprint of $427 as recorded in the federal CMS Open Payments database.

$427 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALVAREZ NUNEZ's primary funding source is GENZYME CORPORATION, which accounts for $117 (representing 27.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GENZYME CORPORATION

Rank 1

$117

27.3%

SOBI

Rank 2

$116

27.1%

TERUMO BCT

Rank 3

$115

26.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.